TNPSC Thervupettagam

Covishield Controversy

May 4 , 2024 39 days 190 0
  • Controversy erupted when UK-based pharmaceutical giant AstraZeneca admitted that its Covid vaccine could cause blood clot-related side effects 'in very rare cases'.
  • Its legal document mentioned that, this vaccine could cause Thrombosis with Thrombocytopenia Syndrome (TTS) in “very rare cases”.
  • The very same vaccine was manufactured by the Serum Institute of India (SII) and was known in India as Covishield.
  • TTS is a rare condition characterized by the formation of blood clots (thrombosis) accompanied by low platelet count (thrombocytopenia).

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *